Agility LP Ankle Arthroplasty Outcomes

November 20, 2012 updated by: John G. Anderson, MD, Orthopaedic Associates of Michigan, PC

Agility LP Ankle Arthroplasty: Clinical and Radiographic Outcomes

This is a research study which is being done to determine the outcomes following Agility LP ankle replacement. This implant was approved by the FDA in 2007 and has been used since then with good early results. You are being asked to volunteer for this study because you have undergone Total Ankle Arthroplasty with Agility LP prosthesis. The purpose of the study is to compare the range of motion, level of pain and function during daily living prior to and after your ankle surgery.

Study Overview

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Grand Rapids, Michigan, United States, 49525
        • Orthopaedic Associates of Michigan, PC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Female and male subjects over the age of 18 at the time of procedure who have undergone ankle joint replacement using the DePuy Agility LP Device.

Description

Inclusion Criteria:

  • Over 18 years old
  • Can comprehend and sign the informed consent
  • Patient must have undergone Agility LP ankle replacement between January 2006 to June 2008

Exclusion Criteria:

  • Patient has had following procedures on the study limb within two years of TAA
  • Revision of TAA
  • Ankle arthrodesis
  • Amputation
  • Agility LP arthroplasty was done as a revision procedure for a failed TAA or as a takedown of ankle fusion.
  • Any condition that, in the opinion of the investigator, makes the patient unsuitable for participation in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of Functional Outcomes Following Agility LP Ankle Replacement
Time Frame: A Minimum of 2 Years Post Index Procedure
Range of Motion - Combined total of dorsiflexion and plantarflexion. Full range of motion is described as 30 degrees or more. Partial limitation is described as 29 to 15 degrees. Range of motion that is less than 15 degrees is described as severely limited.
A Minimum of 2 Years Post Index Procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of Complication and Reoperation Rates
Time Frame: A Minimum of 2 Years Post Index Procedure
Number of reported complications/reoperations following the index procedure.
A Minimum of 2 Years Post Index Procedure
Radiographic Predictors of Implant Failures and Poor Outcomes
Time Frame: A Minimum of 2 Years Post Index Procedure
Post-Operative radiographic disposition. Subsidence is described as the component sinking into the bone. Ingrowth is described as the implant components to conform into the tibia and talus.
A Minimum of 2 Years Post Index Procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: John G Anderson, MD, Orthopaedic Associates of Michigan, PC

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2010

Primary Completion (Actual)

August 1, 2012

Study Completion (Actual)

September 1, 2012

Study Registration Dates

First Submitted

June 2, 2011

First Submitted That Met QC Criteria

June 3, 2011

First Posted (Estimate)

June 6, 2011

Study Record Updates

Last Update Posted (Estimate)

December 20, 2012

Last Update Submitted That Met QC Criteria

November 20, 2012

Last Verified

November 1, 2012

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • OAM-LP-2010

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rheumatoid Arthritis of Ankle

Subscribe